These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11294516)

  • 1. Oxybutynin does not affect cyclosporin blood levels.
    Springate JE
    Ther Drug Monit; 2001 Apr; 23(2):155-6. PubMed ID: 11294516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New adverse effect of oxybutynin: "night terror".
    Valsecia ME; Malgor LA; Espíndola JH; Carauni DH
    Ann Pharmacother; 1998 Apr; 32(4):506. PubMed ID: 9562151
    [No Abstract]   [Full Text] [Related]  

  • 3. Is attempting suicide an adverse effect of oxybutynin in a child with enuresis nocturna?
    Coskun S; Yüksel H; Onag A
    Pediatr Emerg Care; 2001 Oct; 17(5):398. PubMed ID: 11673723
    [No Abstract]   [Full Text] [Related]  

  • 4. Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida.
    Ferrara P; D'Aleo CM; Tarquini E; Salvatore S; Salvaggio E
    BJU Int; 2001 May; 87(7):674-8. PubMed ID: 11350411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, tolerability and safety of propiverine hydrochloride in comparison to oxybutynin in children with urge incontinence due to overactive bladder: Results of a multicentre observational cohort study.
    Alloussi S; Mürtz G; Braun R; Gerhardt U; Heinrich M; Hellmis E; Horn W; Marschall-Kehrel D; Niklas K; Raabe M; Rössler T; Seibt B; Siemer S; Schultz-Lampel D; Walter H; Wiedeking B; Alloussi S; Bock P; Strugala G; Madersbacher H
    BJU Int; 2010 Aug; 106(4):550-6. PubMed ID: 20002668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravesical oxybutynin in children with meningomyelocele. Efficient treatment with few side-effects].
    Von Zweigbergk M; Nordin B; Jonsson S
    Lakartidningen; 1996 Oct; 93(41):3573-6. PubMed ID: 8965514
    [No Abstract]   [Full Text] [Related]  

  • 7. Complications of intravesical oxybutynin chloride therapy in the pediatric myelomeningocele population.
    Palmer LS; Zebold K; Firlit CF; Kaplan WE
    J Urol; 1997 Feb; 157(2):638-40. PubMed ID: 8996387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute-angle closure glaucoma as a side-effect of oxybutynin.
    Sung VC; Corridan PG
    Br J Urol; 1998 Apr; 81(4):634-5. PubMed ID: 9598644
    [No Abstract]   [Full Text] [Related]  

  • 9. Exaggerated neurological side-effects of oral and intravesical oxybutynin in a patient with multiple sclerosis.
    Vaidyanathan S; Krishnan KR; Soni BM; Fraser MH
    Spinal Cord; 1997 Mar; 35(3):190-1. PubMed ID: 9076875
    [No Abstract]   [Full Text] [Related]  

  • 10. Interleukin-2 receptor antibody-induced alterations of ciclosporin dose requirements in paediatric transplant recipients.
    Strehlau J; Pape L; Offner G; Nashan B; Ehrich JH
    Lancet; 2000 Oct; 356(9238):1327-8. PubMed ID: 11073027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between oxybutynin and neuropsychiatric adverse effects not confirmed in daily practice.
    Movig KL; Egberts AC; Lenderink AW; Leufkens HG
    J Am Geriatr Soc; 2001 Feb; 49(2):234-5. PubMed ID: 11207885
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of absorption profiling on efficacy and safety of cyclosporin therapy in transplant recipients.
    Belitsky P; Dunn S; Johnston A; Levy G
    Clin Pharmacokinet; 2000 Aug; 39(2):117-25. PubMed ID: 10976658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring of immunosuppressant drugs in Marmara University Hospital.
    Karaalp A; Demir D; Gören MZ; Akc A; ISkender E; Yananl HR; Ozyurt H; Ozkaynakç A; Berkman K; Oktay S; Onat F
    Ther Drug Monit; 2004 Jun; 26(3):263-6. PubMed ID: 15167625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of oxybutynin treatment on cognition in children with diurnal incontinence.
    Sommer BR; O'Hara R; Askari N; Kraemer HC; Kennedy WA
    J Urol; 2005 Jun; 173(6):2125-7. PubMed ID: 15879864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic monitoring of immunosuppressive effects indicates reduced cyclosporine activity during telaprevir therapy.
    Roos K; Gotthardt D; Giese T; Schnitzler P; Stremmel W; Czock D; Eisenbach C
    Liver Transpl; 2014 Sep; 20(9):1106-17. PubMed ID: 24890314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of simvastatin and pravastatin on hyperlipidemia and cyclosporin blood levels in renal transplant recipients.
    Capone D; Stanziale P; Gentile A; Imperatore P; Pellegrino T; Basile V
    Am J Nephrol; 1999; 19(3):411-5. PubMed ID: 10393380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of hyposalivation caused by oxybutynin chloride in the treatment of the unstable bladder].
    Arango Toro O; Nohales Taurines G; Cortadellas Angel R; Castro Santamaría R; Gelabert Mas A
    Actas Urol Esp; 1998 Feb; 22(2):124-30. PubMed ID: 9586268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride.
    Katz IR; Sands LP; Bilker W; DiFilippo S; Boyce A; D'Angelo K
    J Am Geriatr Soc; 1998 Jan; 46(1):8-13. PubMed ID: 9434659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic use of oxybutynin and spinal anesthesia: a case of postoperative urinary retention and hematuria.
    Hobaika AB
    Middle East J Anaesthesiol; 2011 Oct; 21(3):431-2. PubMed ID: 22428504
    [No Abstract]   [Full Text] [Related]  

  • 20. Itraconazole moderately increases serum concentrations of oxybutynin but does not affect those of the active metabolite.
    Lukkari E; Juhakoski A; Aranko K; Neuvonen PJ
    Eur J Clin Pharmacol; 1997; 52(5):403-6. PubMed ID: 9272412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.